FBXO18 Antibodies

Santa Cruz Biotechnology offers a broad range of FBXO18 monoclonal antibodies for research focused on understanding FBXO18 protein functions. FBXO18 Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FBXO18 is a member of the F-box protein family, which plays a vital role in the ubiquitin-proteasome pathway, a key mechanism for protein degradation and regulation within the cell. FBXO18 participates in cell cycle regulation and influences various cellular processes, making it essential for maintaining cellular homeostasis. Research has shown that FBXO18 may have significant implications in cancer development and progression. Scientists studying FBXO18 continue to uncover new insights about its cellular functions and regulatory mechanisms. Understanding FBXO18's role in normal cellular processes can lead to breakthroughs in disease treatment strategies. Current research indicates that FBXO18 could be a promising therapeutic target for various pathological conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of FBXO18 and its potential therapeutic applications.